On Monday, for the second time in as many business days, Illumina (NASDAQ: ILMN) stock took it on the chin because of an ...
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 37% bearish. Among these notable options, 4 are puts, totaling $366,099, and 4 are calls, amounting to ...
Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Loop Capital upgraded Aspen Technology (AZPN) to Buy from Hold with a price target of $315, up from $265. The firm believes ...
Illumina (NASDAQ:ILMN – Free Report) had its target price trimmed by Barclays from $145.00 to $130.00 in a research report report published on Monday morning,Benzinga reports. The brokerage currently ...
Illumina has struggled to boost sales and consistently deliver positive earnings. Its Q4 report was largely a disappointment, and management's 2025 guidance came in below Wall Street's ...